The rapid advances in genome technologies and the bioinformatics challenges in interpreting massive amounts of data have created amazing opportunities for young researchers. The BIG program offers an interdisciplinary PhD training aimed at producing leading researchers in these areas. Most of our students come with a very strong background in a quantitative field as well as a significant experience in molecular biology and genetics.
The BIG program is administered by the Department of Biomedical Informatics at Harvard Medical School, located in Boston, Massachusetts. The students have a substantial flexibility in choosing their advisors--they can choose practically any faculty members who have a primary appointment at Harvard, in addition to the core faculty members listed on this site. Our core faculty is unparalleled in its record high-quality research in many areas of genomics and bioinformatics, both in basic science and translational research.... Read more about Welcome to BIG
We were delighted to welcome our new entering class last week for an in-person orientation. Our cohort is 13 students this year.
Our students have undergraduate degrees in computational biology, mathematics, statistics and data science, biomedical engineering (2), statistics, computer science, applied biology with biotechnology, bichemistry and molecular biology, neuroscience, bioinformatics (biological/genomic sciences), biology (genomics and computational biology), and engineering science and applied mathematics; two with master's degrees, and two MD/PhD...
We would like to extend a very special welcome to our entering BIG class. From cities near and far, students joined together for this virtual greeting and orientation as we began the new academic year. With 14 students, it is the largest BIG cohort ever.... Read more about BIG Program Welcomes 2020-2021 Class
BIG student Anika Gupta launched a new podcast: The Data Pulse. The Data Pulse dives into the growing role that data science plays in biotechnology and biomedical innovations, through conversations with veterans and rising stars at that intersection--spanning academia and industry, and ranging from the molecular to the clinical scales.